Subsequently, KRT18 was found to be abnormally expressed in various malignant tumours and was gradually regarded as a diagnostic and prognostic marker in cancers, including gastric cancer [9, 10], non–small cell lung cancer [11], hepatocellular cancer [12], and colorectal cancer [13]. The gene discussed is KRT18; the disease is cancer.